Donald Levy • UCI Profiles

Donald S Levy

Title(s)	Health Sciences Professor, Medicine
School	School of Medicine
Address	1001 Health Sciences Road Irvine CA 92697-3950
Phone	(949) 824-5818
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy. Allergy Asthma Proc. 2024 Jan 01; 45(1):44-49. Lumry WR, Bernstein JA, Li HH, Levy DS, Jones DH, Padilla BE, Li-Mcleod J, Tachdjian R. PMID: 38151740.

View in: PubMed Mentions: 1 Fields:
All Allergy and Immunology Pul Pulmonary Medicine
Translation:Humans
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2022 03 05; 399(10328):945-955. Craig T, Magerl M, Levy DS, Reshef A, Lumry WR, Martinez-Saguer I, Jacobs JS, Yang WH, Ritchie B, Aygören-Pürsün E, Keith PK, Busse P, Feuersenger H, Pawaskar D, Jacobs I, Pragst I, Doyle MK. PMID: 35219377.

View in: PubMed Mentions: 10 Fields:
Med Medicine (General)
Translation:Humans
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis. 2021 Jul 28; 16(1):329. Lumry WR, Zuraw B, Cicardi M, Craig T, Anderson J, Banerji A, Bernstein JA, Caballero T, Farkas H, Gower RG, Keith PK, Levy DS, Li HH, Magerl M, Manning M, Riedl MA, Lawo JP, Prusty S, Machnig T, Longhurst H, COMPACT Investigators. PMID: 34321052; PMCID: PMC8317315.

View in: PubMed Mentions: Fields:
Med Medicine (General)
Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy. Allergy Asthma Clin Immunol. 2021 Jun 27; 17(1):60. Anderson J, Levy DS, Lumry W, Koochaki P, Lanar S, Henry Li H. PMID: 34176500; PMCID: PMC8237414.

View in: PubMed Mentions: 4
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study. Orphanet J Rare Dis. 2021 02 15; 16(1):86. Lumry WR, Zuraw B, Cicardi M, Craig T, Anderson J, Banerji A, Bernstein JA, Caballero T, Farkas H, Gower RG, Keith PK, Levy DS, Li HH, Magerl M, Manning M, Riedl MA, Lawo JP, Prusty S, Machnig T, Longhurst H, on behalf of the COMPACT Investigators. PMID: 33588897; PMCID: PMC7885603.

View in: PubMed Mentions: 7 Fields:
Med Medicine (General)
Translation:Humans
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial. Allergy Asthma Clin Immunol. 2020; 16:8. Levy DS, Farkas H, Riedl MA, Hsu FI, Brooks JP, Cicardi M, Feuersenger H, Pragst I, Reshef A. PMID: 32042283; PMCID: PMC7001333.

View in: PubMed Mentions: 6
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2018 Sep - Oct; 6(5):1733-1741.e3. Lumry WR, Craig T, Zuraw B, Longhurst H, Baker J, Li HH, Bernstein JA, Anderson J, Riedl MA, Manning ME, Keith PK, Levy DS, Caballero T, Banerji A, Gower RG, Farkas H, Lawo JP, Pragst I, Machnig T, Watson DJ. PMID: 29391286.

View in: PubMed Mentions: 33 Fields:
All Allergy and Immunology
Translation:Humans CTClinical Trials
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017 03 23; 376(12):1131-1140. Longhurst H, Cicardi M, Craig T, Bork K, Grattan C, Baker J, Li HH, Reshef A, Bonner J, Bernstein JA, Anderson J, Lumry WR, Farkas H, Katelaris CH, Sussman GL, Jacobs J, Riedl M, Manning ME, Hebert J, Keith PK, Kivity S, Neri S, Levy DS, Baeza ML, Nathan R, Schwartz LB, Caballero T, Yang W, Crisan I, Hernandez MD, Hussain I, Tarzi M, Ritchie B, Králícková P, Guilarte M, Rehman SM, Banerji A, Gower RG, Bensen-Kennedy D, Edelman J, Feuersenger H, Lawo JP, Machnig T, Pawaskar D, Pragst I, Zuraw BL, COMPACT Investigators. PMID: 28328347.

View in: PubMed Mentions: 59 Fields:
Med Medicine (General)
Translation:Humans CTClinical Trials
IOP variation. Ophthalmology. 2006 Jul; 113(7):1253; author reply 1254. Levy DS. PMID: 16815423.

View in: PubMed Mentions: Fields:
Oph Ophthalmology
Translation:Humans